556 related articles for article (PubMed ID: 23254142)
21. Vancomycin is commonly under-dosed in critically ill children and neonates.
Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
[TBL] [Abstract][Full Text] [Related]
22. Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal.
Tauzin M; Cohen R; Durrmeyer X; Dassieu G; Barre J; Caeymaex L
Front Pediatr; 2019; 7():188. PubMed ID: 31139607
[No Abstract] [Full Text] [Related]
23. Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations.
Colin PJ; Allegaert K; Thomson AH; Touw DJ; Dolton M; de Hoog M; Roberts JA; Adane ED; Yamamoto M; Santos-Buelga D; Martín-Suarez A; Simon N; Taccone FS; Lo YL; Barcia E; Struys MMRF; Eleveld DJ
Clin Pharmacokinet; 2019 Jun; 58(6):767-780. PubMed ID: 30656565
[TBL] [Abstract][Full Text] [Related]
24. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
25. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
26. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
27. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
[TBL] [Abstract][Full Text] [Related]
28. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
29. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
Kadambari S; Heath PT; Sharland M; Lewis S; Nichols A; Turner MA
J Antimicrob Chemother; 2011 Nov; 66(11):2647-50. PubMed ID: 21862473
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
[TBL] [Abstract][Full Text] [Related]
32. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
33. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia.
van der Veer MAA; de Haan TR; Franken LGW; van Hest RM; Groenendaal F; Dijk PH; de Boode WP; Simons S; Dijkman KP; van Straaten HLM; Rijken M; Cools F; Nuytemans DHGM; van Kaam AH; Bijleveld YA; Mathôt RAA;
Br J Clin Pharmacol; 2024 Jun; 90(6):1418-1427. PubMed ID: 38450797
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin: pharmacokinetics and administration regimens in neonates.
de Hoog M; Mouton JW; van den Anker JN
Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
[TBL] [Abstract][Full Text] [Related]
36. How to use vancomycin optimally in neonates: remaining questions.
Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
38. Importance of vancomycin loading doses in intermittent infusion regimens.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
[TBL] [Abstract][Full Text] [Related]
39. Actual body weight-based vancomycin dosing in neonates.
Pokorná P; Šíma M; Černá O; Allegaert K; Tibboel D; Slanař O
J Chemother; 2019 Oct; 31(6):307-312. PubMed ID: 30983533
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
